Di Nuzzo Private Wealth, Inc. Neurocrine Biosciences Inc Transaction History
Di Nuzzo Private Wealth, Inc.
- $617 Million
- Q1 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 8 shares of NBIX stock, worth $861. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8
Previous 14
42.86%
Holding current value
$861
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NBIX
# of Institutions
647Shares Held
95.3MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.53 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.09 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$527 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$325 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$273 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...